A detailed history of Cambiar Investors LLC transactions in Novartis Ag stock. As of the latest transaction made, Cambiar Investors LLC holds 125,609 shares of NVS stock, worth $12.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
125,609
Previous 216,656 42.02%
Holding current value
$12.2 Million
Previous $23.1 Million 37.36%
% of portfolio
0.59%
Previous 0.93%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$106.13 - $120.89 $9.66 Million - $11 Million
-91,047 Reduced 42.02%
125,609 $14.4 Million
Q2 2024

Jul 26, 2024

BUY
$92.57 - $107.37 $6.94 Million - $8.05 Million
74,938 Added 52.88%
216,656 $23.1 Million
Q1 2024

May 02, 2024

SELL
$95.27 - $108.47 $1.37 Million - $1.56 Million
-14,406 Reduced 9.23%
141,718 $13.7 Million
Q4 2023

Jan 25, 2024

SELL
$92.27 - $101.54 $7.62 Million - $8.38 Million
-82,537 Reduced 34.58%
156,124 $15.8 Million
Q3 2023

Oct 30, 2023

SELL
$94.73 - $105.13 $1.64 Million - $1.82 Million
-17,292 Reduced 6.76%
238,661 $24.3 Million
Q2 2023

Jul 31, 2023

SELL
$92.52 - $104.91 $4.79 Million - $5.43 Million
-51,753 Reduced 16.82%
255,953 $25.8 Million
Q1 2023

May 08, 2023

BUY
$80.03 - $92.81 $280,024 - $324,742
3,499 Added 1.15%
307,706 $28.3 Million
Q4 2022

Feb 02, 2023

SELL
$75.55 - $92.52 $1.97 Million - $2.41 Million
-26,041 Reduced 7.89%
304,207 $27.6 Million
Q3 2022

Oct 28, 2022

BUY
$74.61 - $87.26 $24.6 Million - $28.8 Million
330,248 New
330,248 $25.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cambiar Investors LLC Portfolio

Follow Cambiar Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.